| Financial Year |
March 31 2023 |
| Monetary Funds |
1,170,625,354.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
8,958,298.41 |
| Accounts Receivable |
140,499,404.99 |
| Advances to Suppliers |
58,005,412.07 |
| Other Receivables |
3,844,611.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,240,813.48 |
| Dividend Receivable |
-- |
| Inventories |
242,304,429.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,813,127.15 |
| Total Current Assets |
1,677,638,522.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,260,740,193.02 |
| Under-construction Projects |
1,760,179.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
59,062,922.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
991,903.69 |
| Deferred Income Tax Assets |
15,146,910.54 |
| Other Non-Current Assets |
10,739,300.39 |
| Sub-Total of Non-Current Assets |
1,348,441,409.74 |
| Total Assets |
3,026,079,932.57 |
| Short-Term Loans |
139,741,019.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
46,797,741.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,013,838.12 |
| Taxes Payable |
14,450,322.67 |
| Interest Payable |
130,000.00 |
| Dividend Payable |
-- |
| Other payables |
5,673,720.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
3,224,589.78 |
| Sub-Total of Current Liabilities |
244,705,769.57 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,606,892.10 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
58,290,752.39 |
| Total Liabilities |
302,996,521.96 |
| Paid-In Capital(Or Share Stock) |
1,878,360,100.00 |
| Capital Surplus |
812,374,431.53 |
| Surplus Reserve |
38,399,777.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-6,050,898.31 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,723,083,410.61 |
| Owner's Equity（Stockholder's Equity） |
2,723,083,410.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,026,079,932.57 |
